Effects of Realistic In Vitro Test Factors on the Aerosol Properties of Metered-Dose Inhalers – Drug Information Update

If your email program has trouble displaying this email, view it as a web page. Effects of Realistic In Vitro Test Factors on the Aerosol Properties of Metered-Dose Inhalers Metered dose inhalers are mainstays in the treatment of asthma, COPD, and other respiratory diseases. Development of generic inhalation products is challenging, and CDER scientists are helping develop more realistic methods using anatomical models of the mouth-throat region that allow the generic industry to efficiently test their products and speed access to generic inhalation products. Learn more about recent research supporting these efforts. Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA